The Role of Plasma B-type Natriuretic Peptide Measurements in the Differential Diagnosis of Acute Dyspnea |
Moon, Ji Yong
(Department of Internal Medicine, Hanyang University)
Bae, Joong Ho (Department of Internal Medicine, Hanyang University) Kim, Tae Hyung (Department of Internal Medicine, Hanyang University) Sohn, Jang Won (Department of Internal Medicine, Hanyang University) Yoon, Ho Joo (Department of Internal Medicine, Hanyang University) Shin, Dong Ho (Department of Internal Medicine, Hanyang University) Park, Sung Soo (Department of Internal Medicine, Hanyang University) |
1 | Levin ER, Gardner DG, Samson WK. Natriuretic peptide. N Engl J Med 1998;339:321-8 DOI PUBMED ScienceOn |
2 | Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure. J Am Coll Cardiol 1993;22(Suppl A):6A-13A DOI |
3 | Clerico A, Iervasi G, del Chicca MG, Emdin M, Maffei S, Nannipieri M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998;21:170-9 DOI |
4 | Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003;92:1124-7 DOI ScienceOn |
5 | Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel AS. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-9 |
6 | Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-85 DOI ScienceOn |
7 | Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-8 DOI |
8 | Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60 DOI ScienceOn |
9 | Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81 DOI ScienceOn |
10 | Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-8 DOI ScienceOn |
11 | Eimer MJ, Ekery DL, Rigolin VH, Bonow RO, Carnethon MR, Cotts WG. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol 2004;94:676-8 DOI ScienceOn |
12 | Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63 DOI ScienceOn |
13 | Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to Revisethe 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2001;104:2996-3007 DOI ScienceOn |
14 | Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32 DOI PUBMED ScienceOn |
15 | Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996;132:101-7 DOI ScienceOn |
16 | Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7 DOI ScienceOn |
17 | Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54 DOI ScienceOn |
18 | Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000:102;865-70 DOI ScienceOn |
19 | Park HH, Kim S, Choi J, Kim KH, Cheon SC, Lee J, et al. The application of B-type natriuretic peptide level of the dyspneic patients: differentiation between for pulmonary and left ventricular dyfunction. Tuberc Respir Dis 2003;54:320-9 DOI |
20 | Ishii J, Nomura M, Ito M, Naruse H, Mori Y, Wang JH, et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000;301:19-30 DOI PUBMED ScienceOn |
21 | Suttner SW, Boldt J. Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 2004;10:336-41 DOI ScienceOn |